All stock reports

APEX evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-27T23:39:10.659220+00:00

Metrics

latest_annual_period
2026-03-31
revenue
9311375000.0
net_income
388476000.0
operating_cash_flow
923045000.0
free_cash_flow
856605000.0
total_assets
5925848000.0
total_liabilities
645925000.0
total_equity
5279923000.0
cash
185266000.0
total_debt
56771000.0
revenue_growth
0.1445329151508865
earnings_growth
9.021307880820327
net_margin
0.041720583694674525
roe
0.0735760729843977
debt_to_equity
0.01075224013683533
cash_conversion
2.376066989981363
free_cash_flow_margin
0.0919955430857419
trailing_pe
31.0418
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
2.2299
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-d476c6e09294194d5f42c9549831280a3a86a726c2ed392dce0802b04a7c5d5b
Policy
stock-decisions-v1
Evidence bundle hash
b49b37e39cf5e79bc4e35f35ab917c090f9d45b20bc78220d193ec80d6bbdf49
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 78b84889449377afc967059221d2a358ebf8a8a65bdf00bfb70e3060f62ec31b
  • daily-price: 30376ffedc834b666a9ddd4d33af624cdfa8ca97c20c8877fbccf180b845f4ca
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 326.30. The trailing 250-session price return was 43.44%. The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.1445329151508865. The cached financial metric net margin is 0.041720583694674525.

Risks

The trailing 5-session price return was -6.48%. The trailing 20-session price return was -10.56%. The trailing 60-session price return was -14.25%. The closing price was -34.48% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Average cached traded value over twenty sessions was INR 38,182,692. The cached financial metric roe is 0.0735760729843977. The cached financial metric debt to equity is 0.01075224013683533. The cached financial metric cash conversion is 2.376066989981363. The cached financial metric free cash flow margin is 0.0919955430857419.

Cached observations and evidence limits